Literature DB >> 11248535

The effects of gabapentin on different ligand- and voltage-gated currents in isolated cortical neurons.

A Stefani1, F Spadoni, P Giacomini, F Lavaroni, G Bernardi.   

Abstract

A clear picture of the mechanisms of action of the anti-epileptic agent gabapentin is far from being accomplished. We have analyzed the effects of gabapentin on ligand- and voltage-gated currents in isolated adult rat cortical neurons. Gabapentin failed to modify glutamate currents and produced a slight reduction of GABA responses. Negligible inhibition of sodium, but consistent inhibition of high-voltage-activated calcium conductance was promoted by gabapentin. In addition, gabapentin reduced calcium current sensitivity to dihydropyridine agonist and antagonists. Interestingly, gabapentin also decreased a not-inactivating, cadmium-sensitive, potassium current. These unconventional effects might underlie its efficacy in a variety of diseases which involve periodic discharge patterns as neuropathic pain or essential tremor.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11248535     DOI: 10.1016/s0920-1211(00)00201-1

Source DB:  PubMed          Journal:  Epilepsy Res        ISSN: 0920-1211            Impact factor:   3.045


  16 in total

1.  Antiepileptic drugs and cortical excitability: a study with repetitive transcranial stimulation.

Authors:  M Inghilleri; A Conte; V Frasca; A Curra'; F Gilio; M Manfredi; A Berardelli
Journal:  Exp Brain Res       Date:  2003-10-25       Impact factor: 1.972

2.  Down-regulation of N-type voltage-activated Ca2+ channels by gabapentin.

Authors:  Alfonso Vega-Hernández; Ricardo Felix
Journal:  Cell Mol Neurobiol       Date:  2002-04       Impact factor: 5.046

3.  De Novo mutations in GNAO1, encoding a Gαo subunit of heterotrimeric G proteins, cause epileptic encephalopathy.

Authors:  Kazuyuki Nakamura; Hirofumi Kodera; Tenpei Akita; Masaaki Shiina; Mitsuhiro Kato; Hideki Hoshino; Hiroshi Terashima; Hitoshi Osaka; Shinichi Nakamura; Jun Tohyama; Tatsuro Kumada; Tomonori Furukawa; Satomi Iwata; Takashi Shiihara; Masaya Kubota; Satoko Miyatake; Eriko Koshimizu; Kiyomi Nishiyama; Mitsuko Nakashima; Yoshinori Tsurusaki; Noriko Miyake; Kiyoshi Hayasaka; Kazuhiro Ogata; Atsuo Fukuda; Naomichi Matsumoto; Hirotomo Saitsu
Journal:  Am J Hum Genet       Date:  2013-08-29       Impact factor: 11.025

4.  Involvement of NO/cGMP pathway in the antidepressant-like effect of gabapentin in mouse forced swimming test.

Authors:  Sattar Ostadhadi; Nastaran Kordjazy; Arya Haj-Mirzaian; Sanaz Ameli; Golnoosh Akhlaghipour; AhmadReza Dehpour
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2016-01-12       Impact factor: 3.000

5.  Gabapentin Is a Potent Activator of KCNQ3 and KCNQ5 Potassium Channels.

Authors:  Rían W Manville; Geoffrey W Abbott
Journal:  Mol Pharmacol       Date:  2018-07-18       Impact factor: 4.436

6.  Potent analgesic effects of anticonvulsants on peripheral thermal nociception in rats.

Authors:  Slobodan M Todorovic; A J Rastogi; Vesna Jevtovic-Todorovic
Journal:  Br J Pharmacol       Date:  2003-08-04       Impact factor: 8.739

7.  Gabapentin completely attenuated the acute morphine induced c-Fos expression in the rat striatum.

Authors:  Jamil Ahsan Kazi; Chen Fun Gee
Journal:  J Mol Neurosci       Date:  2007       Impact factor: 3.444

8.  Gabapentin alleviates facet-mediated pain in the rat through reduced neuronal hyperexcitability and astrocytic activation in the spinal cord.

Authors:  Ling Dong; Nathan D Crosby; Beth A Winkelstein
Journal:  J Pain       Date:  2013-10-04       Impact factor: 5.820

9.  Modulation of voltage-gated Ca2+ channels in rat retinal ganglion cells by gabapentin.

Authors:  Spring R Farrell; Allison Sargoy; Nicholas C Brecha; Steven Barnes
Journal:  Vis Neurosci       Date:  2014-01       Impact factor: 3.241

10.  Effect of L-methionine on hot flashes in postmenopausal women: a randomized controlled trial.

Authors:  Thomas Guttuso; Michael P McDermott; Phillip Ng; Karl Kieburtz
Journal:  Menopause       Date:  2009 Sep-Oct       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.